Correlation Between Blueprint Medicines and IVERIC Bio
Can any of the company-specific risk be diversified away by investing in both Blueprint Medicines and IVERIC Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blueprint Medicines and IVERIC Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blueprint Medicines Corp and IVERIC Bio, you can compare the effects of market volatilities on Blueprint Medicines and IVERIC Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blueprint Medicines with a short position of IVERIC Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blueprint Medicines and IVERIC Bio.
Diversification Opportunities for Blueprint Medicines and IVERIC Bio
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Blueprint and IVERIC is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Blueprint Medicines Corp and IVERIC Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on IVERIC Bio and Blueprint Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blueprint Medicines Corp are associated (or correlated) with IVERIC Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of IVERIC Bio has no effect on the direction of Blueprint Medicines i.e., Blueprint Medicines and IVERIC Bio go up and down completely randomly.
Pair Corralation between Blueprint Medicines and IVERIC Bio
If you would invest 9,046 in Blueprint Medicines Corp on October 25, 2024 and sell it today you would earn a total of 2,062 from holding Blueprint Medicines Corp or generate 22.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 5.56% |
Values | Daily Returns |
Blueprint Medicines Corp vs. IVERIC Bio
Performance |
Timeline |
Blueprint Medicines Corp |
IVERIC Bio |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Blueprint Medicines and IVERIC Bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Blueprint Medicines and IVERIC Bio
The main advantage of trading using opposite Blueprint Medicines and IVERIC Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blueprint Medicines position performs unexpectedly, IVERIC Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IVERIC Bio will offset losses from the drop in IVERIC Bio's long position.Blueprint Medicines vs. Terns Pharmaceuticals | Blueprint Medicines vs. Amylyx Pharmaceuticals | Blueprint Medicines vs. Acumen Pharmaceuticals | Blueprint Medicines vs. Inozyme Pharma |
IVERIC Bio vs. Blueprint Medicines Corp | IVERIC Bio vs. Amylyx Pharmaceuticals | IVERIC Bio vs. Day One Biopharmaceuticals | IVERIC Bio vs. Immunovant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |